申请人:Brookings Christopher Daniel
公开号:US20060122212A1
公开(公告)日:2006-06-08
A series of 5-6 fused ring bicyclic heteroaromatic derivatives, based in particular on the 5-oxo-4,5-dihydro-1H-pyrrolo[3,2-b]pyridine ring system, being inhibitors of p38 kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.
一系列5-6个融合环的杂环衍生物,特别是基于5-氧代-4,5-二氢-1H-吡咯并[3,2-b]吡啶环系统的,作为p38激酶的抑制剂,在医学上具有用途,例如用于治疗和/或预防免疫或炎症性疾病。